Rejoyn

First cited by AI Oct 1, 2026rejoynmedical.com ↗

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

Rejoyn is losing the AEO war.

Not cited in a single tracked AI answer since Oct 5, 2026, down from a peak of 17% visibility in menopause and women's health on Oct 1, 2026. This page stays public, and recovery shows here the day it happens.

Not cited in Menopause and women's health since Oct 5

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Rejoyn, through Oct 26, 2026.

0.0%

Last cited Oct 5, 2026 · peak 17% on Oct 1

By engine

Where Rejoyn is strong, and where it is invisible.

No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

1 positive mentions
0 neutral
0 mixed or cautious

Recent AI answers mentioning Rejoyn

ClaudeOct 1, 2026, 11:31 UTC

What is the best non hormonal treatment for hot flashes?

Best Non-Hormonal Treatments for Hot Flashes Prescription Options (Most Effective) Veozah (fezolinetant) - FDA-approved specifically for hot flashes; blocks nerve signals that trigger them. Currently the gold standard non-hormonal option Effexor (venlafaxine) - An antidepressant shown to significantly reduce hot flash frequency Brisdelle (paroxetine) - The only FDA-approved SSRI specifically for hot flashes Over-the-Counter Supplements Remifemin (Black Cohosh) - One of the most studied herbal options with decent evidence Equelle (S-equol) - A soy-derived supplement with good clinical backing Relizen - A pollen extract supplement with positive research behind it Lifestyle Approaches Staying cool - Cooling pillows like Chillow or mattress pads like Eight Sleep Cognitive Behavioral Therapy (CBT) - Apps like Rejoyn or programs through therapists Regular exercise - Shown to reduce severity Important Note 👉 Talk to your doctor before starting any treatment, as effectiveness varies by person and some options may interact with medications. Would you like more detail on any of these options?

Mentioned in position 6 of 6

Read full answer with sources →

TL;DR

Rejoyn, operating at rejoynmedical.com, is a telehealth company focused on women's health and menopause care. It offers prescription and wellness services tailored to women navigating hormonal changes and related conditions. According to WellRank's latest index, Rejoyn currently ranks eighth in the Menopause and Women's Health category with 17% AI visibility, and the single mention captured in WellRank's corpus carries a positive tone.

Company Overview

Rejoyn is a telehealth platform built around women's health, with a particular focus on menopause management and hormonal wellness. Its business model centers on connecting patients with clinicians online and facilitating access to prescription therapies and supportive care plans. Founding details and headquarters are not publicly disclosed in widely available sources.

Product Features

Telehealth consultations with clinicians specializing in menopause and women's hormonal health
Prescription hormone therapy access via its online platform
Personalized treatment plans addressing menopause symptoms
Ongoing care coordination and follow-up through a digital interface
Educational resources related to menopause and women's wellness

Target Market

Rejoyn primarily serves women experiencing perimenopause, menopause, and related hormonal health concerns. Its telehealth model suggests it is accessible to patients in the United States, though specific geographic coverage is not publicly detailed. The platform is designed for women seeking convenient, clinician-guided care without traditional in-office barriers.

Buyer Personas

A woman in her late forties experiencing early perimenopause symptoms who prefers managing her care remotely rather than scheduling repeated in-person appointments.
A postmenopausal woman seeking ongoing hormonal therapy management and looking for a digital-first provider who specializes in this stage of life.
A busy professional in her fifties who wants streamlined access to prescription menopause treatments without long waits at a traditional OB-GYN office.
A health-conscious woman researching evidence-based menopause solutions and comparing telehealth options before committing to a treatment plan.

Funding & Performance

Funding stage, investment amounts, and valuation for Rejoyn are not publicly disclosed in widely available sources. Its public or private status and overall company scale have not been confirmed through major financial reporting.

Recent Developments

Rejoyn has been surfacing organically in AI-generated answers about menopause and women's health, suggesting growing recognition in this competitive telehealth segment. The company appears to be expanding its profile in the women's health space, though specific product launches or partnerships have not been widely reported in verifiable public sources.

Competitive Landscape

Based on WellRank co-mention data, AI engines most frequently cite Rejoyn alongside Remifemin, Relizen, Equelle, Eight Sleep, and Chillow when answering questions about menopause and women's health. This places Rejoyn in a field that mixes prescription telehealth services with over-the-counter supplement brands and sleep-focused wellness products, reflecting the broad range of solutions consumers consider for menopause symptom relief. Rejoyn's prescription-focused telehealth model differentiates it from the supplement competitors in this co-mention cluster.

Rejoyn vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

Brand	Rank	AI visibility	Avg position	Sentiment
RejoynThis brand	–	0.0%	-	positive85
Equelle 1 shared answers	#20	8.3%	3.0	positive81
Relizen 1 shared answers	#46	8.3%	3.0	positive82
Remifemin 1 shared answers	#5	25.0%	2.0	positive76

Email me when overtakes Rejoyn

One email the day the ranks flip. Nothing else.

User Sentiment

Within WellRank's AI-answer corpus, Rejoyn's single captured mention carries a positive tone, with no neutral or cautious characterizations recorded to date. This early signal suggests AI engines introduce the brand favorably in relevant conversations, though the limited sample size means the sentiment picture may evolve as the brand gains more AI visibility. Public consumer reviews and broader social sentiment are not yet widely documented in major review aggregators.

Pricing

Pricing for Rejoyn's telehealth consultations and treatment plans is not published in widely available sources. Pricing likely varies depending on the type of consultation, prescribed therapies, and any subscription or membership structure the platform may use, but specific figures have not been confirmed publicly.

Sources cited around Rejoyn

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Rejoyn weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Rejoyn? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.